🚨 Pediatric Type 2 Diabetes: Limited Options, Critical Decisions

Did you know?

For children ≥10 years, treatment choices are still very limited.

💊 Approved Oral Options:

• Metformin (first-line)
• Empagliflozin
• Empagliflozin + Metformin

💉 Approved Injectables:

• Liraglutide
• Exenatide
• Dulaglutide

💡 Why this matters:

Early, appropriate therapy can change lifelong outcomes—from complications to confidence.

⚠️ The challenge?

Balancing efficacy, safety, and adherence in young patients.

👨‍⚕️ The opportunity?

Timely, personalized intervention can rewrite a child’s metabolic future.

👉 Are we optimizing treatment early enough?

#PediatricDiabetes #Type2Diabetes #Diabetology #ChildHealth #Endocrinology #DiabetesCare #MedicalEducation #HealthcareInnovation #ChronicCare #MasterDoctorWellness